Poor staging and treatment are likely to be behind low bowel cancer survival in UKBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2485 (Published 17 April 2013) Cite this as: BMJ 2013;346:f2485
- Zosia Kmietowicz
Lower survival among people with bowel cancer in the United Kingdom than among those in similar countries is likely to be because of poor staging and unequal access to the best treatment, new findings indicate.
A study led by the London School of Hygiene and Tropical Medicine was carried out in Australia, Canada, Denmark, Norway, Sweden, and the UK for the International Cancer Benchmarking Partnership. It included more than 310 000 patients whose bowel cancer was diagnosed between 2000 and 2007.
The researchers used population based cancer registries to examine how far the patients’ cancer had spread at the time of diagnosis and to look at the proportion …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial